STAT+ | FDA Petitioned to Recall Batches of Metformin Diabetes Pill Over a Possible Carcinogen

STAT+ released an article titled, "FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen." This piece highlights Valisure's March 2, 2020, announcement of detecting high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.

View the full article via STAT+ here.

STAT+ | FDA Petitioned to Recall Batches of Metformin Diabetes Pill Over a Possible Carcinogen

May 2, 2022

STAT+ released an article titled, "FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen." This piece highlights Valisure's March 2, 2020, announcement of detecting high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.

View the full article via STAT+ here.

STAT+ | FDA Petitioned to Recall Batches of Metformin Diabetes Pill Over a Possible Carcinogen

STAT+ released an article titled, "FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen." This piece highlights Valisure's March 2, 2020, announcement of detecting high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.

View the full article via STAT+ here.

STAT+ released an article titled, "FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen." This piece highlights Valisure's March 2, 2020, announcement of detecting high levels of N-Nitrosodimethylamine (NDMA) in specific lots of the drug metformin, a prescription medication used to control high blood sugar in adults and adolescents with type 2 diabetes.

View the full article via STAT+ here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.